XML 20 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Loan Payable - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended
Jan. 31, 2014
Jul. 31, 2013
Apr. 30, 2013
Sep. 30, 2012
Mar. 31, 2014
Debt Instrument [Line Items]          
Proceeds from loan         $ 3,820,264
Loan term         3 years
Annual interest rate on loan         6.00%
Period of loan subject to interest payments only         6 months
Period of loan subject to principal and interest payments         30 months
Final fee payment at the end of loan term         1,000,000
Proceeds received under loan agreement         9,900,000
Initial carrying amount assigned to loan, net of discount         9,512,000
Fair value allocated to warrant         388,000
Cash discount         100,000
Note issuance costs         117,000
Deferred financing costs, discount and accretion percentage         9.00%
CIRM Loan Agreement [Member]
         
Debt Instrument [Line Items]          
Proceeds from loan         3,820,264
Loan term       10 years  
Approval of fund by California Institute for Regenerative Medicine (CIRM)     19,300,000    
Approval of fund by California Institute for Regenerative Medicine (CIRM) maximum period       4 years  
Loan interest rate description         One year LIBOR rate plus two percent
LIBOR rate plus percentage         2.00%
LIBOR rate plus percentage increase         1.00%
Proceeds from initial disbursement of the loan 3,800,000 3,800,000      
Silicon Valley Bank Loan Agreement Warrant [Member]
         
Debt Instrument [Line Items]          
Term of warrant expiration         10 years
Exercise price of warrant         1.7034
Warrant expiration period         April 2023
Silicon Valley Bank Loan Agreement Warrant [Member] | Common Stock [Member]
         
Debt Instrument [Line Items]          
Number of shares of common stock acquired using warrant         293,531
Silicon Valley Bank [Member]
         
Debt Instrument [Line Items]          
Proceeds from loan     $ 9,900,000